| Title |
Noncoding RNAs Involved in Mammary Gland Development and Tumorigenesis: There’s a Long Way to Go
|
|---|---|
| Published in |
Journal of Mammary Gland Biology and Neoplasia, March 2012
|
| DOI | 10.1007/s10911-012-9247-3 |
| Pubmed ID | |
| Authors |
Amy N. Shore, Jason I. Herschkowitz, Jeffrey M. Rosen |
| Abstract |
The mammalian genome encodes thousands of noncoding RNAs. These noncoding transcripts are broadly categorized into short noncoding RNAs, such as microRNAs (miRNAs), and long noncoding RNAs (lncRNAs) of greater than 200 nt. While the role of miRNAs in development and cancer biology has been extensively studied, much less is known about the vast majority of noncoding transcripts represented by lncRNAs. LncRNAs are emerging as key regulators of developmental processes and as such, their frequent misregulation in tumorigenesis and disease in not unexpected. The role of lncRNAs in mammary gland development and breast cancer is just beginning to be elucidated. This review will discuss the role of lncRNAs in mammalian and mammary gland development. In addition, we will review the contributions of lncRNAs to the stepwise progression of tumorigenesis, highlighting the role of lncRNAs in breast cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 2% |
| United Kingdom | 1 | 2% |
| Hungary | 1 | 2% |
| United States | 1 | 2% |
| Unknown | 50 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 39% |
| Student > Ph. D. Student | 10 | 19% |
| Professor | 5 | 9% |
| Professor > Associate Professor | 4 | 7% |
| Student > Master | 4 | 7% |
| Other | 5 | 9% |
| Unknown | 5 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 23 | 43% |
| Biochemistry, Genetics and Molecular Biology | 14 | 26% |
| Medicine and Dentistry | 8 | 15% |
| Immunology and Microbiology | 2 | 4% |
| Chemical Engineering | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 5 | 9% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2021.
All research outputs
#7,390,600
of 23,867,274 outputs
Outputs from Journal of Mammary Gland Biology and Neoplasia
#120
of 367 outputs
Outputs of similar age
#47,703
of 158,852 outputs
Outputs of similar age from Journal of Mammary Gland Biology and Neoplasia
#4
of 6 outputs
Altmetric has tracked 23,867,274 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 367 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.